Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chayma Ladhari

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Therapie|May 19, 2020
Incretin-based drugs and intestinal obstruction: A pharmacovigilance studyBastien Gudin, Chayma Ladhari, Perrine Robin, et al.
Pharmacogenomics|June 20, 2018
Codeine-induced acute generalized exanthematous pustulosis without IL36RN mutationsZohra Chadli, Chayma Ladhari, Emna Kerkeni, et al.
BMC Rheumatology|March 13, 2020
Successful long-term remission through tapering tocilizumab infusions: a single-center prospective studyChayma Ladhari, Pierre Le Blay, Thierry Vincent, et al.
Cancer Immunology, Immunotherapy : CII|May 26, 2022
Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance studyPascale Palassin, Alexandre T J Maria, Chayma Ladhari, et al.
Journal of Clinical Laboratory Analysis|April 23, 2023
Laboratory diagnosis of heparin-induced thrombocytopenia: A retrospective experienceAgathe Herb, Mathilde Depierreux, Jordan Wimmer, et al.
The Pharmacogenomics Journal|January 17, 2019
A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patientsCécile Luxembourger, Adeline Ruyssen-Witrand, Chayma Ladhari, et al.
Frontiers in Medicine|January 4, 2021
Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World SettingNicolas Gendron, Richard Chocron, Paul Billoir, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Therapie|May 19, 2020
Incretin-based drugs and intestinal obstruction: A pharmacovigilance studyBastien Gudin, Chayma Ladhari, Perrine Robin, et al.
Pharmacogenomics|June 20, 2018
Codeine-induced acute generalized exanthematous pustulosis without IL36RN mutationsZohra Chadli, Chayma Ladhari, Emna Kerkeni, et al.
BMC Rheumatology|March 13, 2020
Successful long-term remission through tapering tocilizumab infusions: a single-center prospective studyChayma Ladhari, Pierre Le Blay, Thierry Vincent, et al.
Cancer Immunology, Immunotherapy : CII|May 26, 2022
Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance studyPascale Palassin, Alexandre T J Maria, Chayma Ladhari, et al.
Journal of Clinical Laboratory Analysis|April 23, 2023
Laboratory diagnosis of heparin-induced thrombocytopenia: A retrospective experienceAgathe Herb, Mathilde Depierreux, Jordan Wimmer, et al.
The Pharmacogenomics Journal|January 17, 2019
A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patientsCécile Luxembourger, Adeline Ruyssen-Witrand, Chayma Ladhari, et al.
Frontiers in Medicine|January 4, 2021
Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World SettingNicolas Gendron, Richard Chocron, Paul Billoir, et al.
Pageof 1